Identification of Immune-Related Risk Characteristics and Prognostic Value of Immunophenotyping in TNBC

Background: Triple-negative breast cancer (TNBC) is not sensitive to targeted therapy with HER-2 monoclonal antibody and endocrine therapy due to lack of ER, PR, and HER-2 receptors. TNBC is a breast cancer subtype with the worst prognosis and the highest mortality rate compared with other subtypes....

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Jiarong, Shuang, Zeyu, Zhong, Wenjing, Wu, Haoming, Feng, Jikun, Zouxu, Xiazi, Huang, Xinjian, Li, Siqi, Wang, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586457/
https://www.ncbi.nlm.nih.gov/pubmed/34777466
http://dx.doi.org/10.3389/fgene.2021.730442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586457/
https://www.ncbi.nlm.nih.gov/pubmed/34777466
http://dx.doi.org/10.3389/fgene.2021.730442

Ejemplares similares